UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 98

Sortiert nach

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression

Leukemia, 2010-06, Vol.24 (6), p.1139-1145

2010

Volltextzugriff (PDF)

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

Blood, 2006-11, Vol.108 (10), p.3548-3555

2006

Volltextzugriff (PDF)

PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R‐DA‐EPOCH

HemaSphere, 2022-06, Vol.6 (Suppl), p.1998-1999

2022

Volltextzugriff (PDF)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes

Leukemia, 2016-12, Vol.30 (12), p.2322-2331

2016

Volltextzugriff (PDF)

P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID‐19 PATIENTS

HemaSphere, 2022-06, Vol.6 (Suppl), p.1572-1573

2022

Volltextzugriff (PDF)

P1040: HIGHER ESTIMATED PLASMA VOLUME STATUS IS ASSOCIATED WITH INCREASED THROMBOTIC RISK AND IMPAIRED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS

HemaSphere, 2022-06, Vol.6 (Suppl), p.930-931

2022

Volltextzugriff (PDF)

P1039: PALPABLE SPLEEN SIZE IS PROGNOSTIC IN PRIMARY BUT NOT SECONDARY MYELOFIBROSIS

HemaSphere, 2022-06, Vol.6 (Suppl), p.929-930

2022

Volltextzugriff (PDF)

P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID‐19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1473-1474

2022

Volltextzugriff (PDF)

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)

Blood, 2005-10, Vol.106 (8), p.2849-2853

2005

Volltextzugriff (PDF)

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia

Leukemia, 2006-04, Vol.20 (4), p.671-679

2006

Volltextzugriff (PDF)

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features

Therapeutics and clinical risk management, 2021-01, Vol.17, p.1037-1044

2021

Volltextzugriff (PDF)

37 Diffuse skin hyperpigmentation in CD30+ lymphoproliferation: A case report

European journal of cancer supplements, 2010, Vol.8 (4), p.20-21

2010

Volltextzugriff (PDF)

IMPACT OF ANGIOTENSIN-CONVERTING ENZYME INSERTION/DELETION POLYMORPHISM ON BLOOD PRESSURE AND PROTEIN EXCRETION IN PATIENTS WITH OVERT PROTEINURIA: PP.25.289

Journal of hypertension, 2011-06, Vol.29, p.e378

2011

Volltextzugriff (PDF)

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia

Leukemia, 1997-05, Vol.11 (5), p.639-643

1997

Volltextzugriff (PDF)

P041 Molecular detection and clinics of IgH/MMSET of t(4;14)(4p16;14q32) in multiple myeloma

Leukemia research, 2007, Vol.31, p.S83-S83

2007

Volltextzugriff (PDF)

P034 Bone marrow renin-angiotensin system expression in polycythaemia vera and essential thrombocythaemia depends on JAK2 mutational status

Leukemia research, 2007, Vol.31, p.S80-S80

2007

Volltextzugriff (PDF)

561 Renin-angiotensin system expression in myeloproliferative diseases

European journal of cancer supplements, 2010, Vol.8 (5), p.143-143

2010

Volltextzugriff (PDF)

Telomere length in myelodysplastic syndromes

American journal of hematology, 1997-12, Vol.56 (4), p.266-271

1997

Volltextzugriff (PDF)

PS1452 GLI‐1, EFFECTOR OF CANONICAL HEDGEHOG SIGNALING PATHWAY, DOES NOT SEEM TO BE DYSREGULATED IN PATIENTS WITH MYELOFIBROSIS

HemaSphere, 2019-06, Vol.3 (S1), p.668-n/a

2019

Volltextzugriff (PDF)

The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia

Haematologica (Roma), 2000-12, Vol.85 (12), p.1261

2000

Volltextzugriff (PDF)

Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension

Collegium antropologicum, 2013-09, Vol.37 (3), p.765-770

2013

Volltextzugriff (PDF)

Amplification of mitochondrial DNA in acute myeloid leukaemia

British journal of haematology, 1996-11, Vol.95 (2), p.426-431

1996

Volltextzugriff (PDF)

Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemia

Haematologica (Roma), 2001-08, Vol.86 (8), p.827

2001

Volltextzugriff (PDF)

B and CTL responses to the ALK protein in patients with ALK‐positive ALCL

International journal of cancer, 2006-02, Vol.118 (3), p.688-695

2006

Volltextzugriff (PDF)

PARATHYROID HORMONE RELATED PROTEIN (PTHrP) IN ACUTE MYELOID LEUKAEMIA CELLS

British journal of haematology, 1997-07, Vol.98 (1), p.245-246

1997

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(63)
Science & Technology
(63)
Life Sciences & Biomedicine
(61)
Male
(36)
Female
(32)
Middle Aged
(32)
Biological And Medical Sciences
(27)
Hematology
(27)
Aged
(26)
Medical Sciences
(26)
Adult
(25)
Hematologic And Hematopoietic Diseases
(18)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(18)
Oncology
(11)
Adolescent
(9)
Aged, 80 And Over
(9)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Prognosis
(9)
Gene Expression
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression

Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation

PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R‐DA‐EPOCH

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes

P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID‐19 PATIENTS

P1040: HIGHER ESTIMATED PLASMA VOLUME STATUS IS ASSOCIATED WITH INCREASED THROMBOTIC RISK AND IMPAIRED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS

P1039: PALPABLE SPLEEN SIZE IS PROGNOSTIC IN PRIMARY BUT NOT SECONDARY MYELOFIBROSIS

P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID‐19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features

37 Diffuse skin hyperpigmentation in CD30+ lymphoproliferation: A case report

IMPACT OF ANGIOTENSIN-CONVERTING ENZYME INSERTION/DELETION POLYMORPHISM ON BLOOD PRESSURE AND PROTEIN EXCRETION IN PATIENTS WITH OVERT PROTEINURIA: PP.25.289

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia

P041 Molecular detection and clinics of IgH/MMSET of t(4;14)(4p16;14q32) in multiple myeloma

P034 Bone marrow renin-angiotensin system expression in polycythaemia vera and essential thrombocythaemia depends on JAK2 mutational status

561 Renin-angiotensin system expression in myeloproliferative diseases

Telomere length in myelodysplastic syndromes

PS1452 GLI‐1, EFFECTOR OF CANONICAL HEDGEHOG SIGNALING PATHWAY, DOES NOT SEEM TO BE DYSREGULATED IN PATIENTS WITH MYELOFIBROSIS

The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia

Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension

Amplification of mitochondrial DNA in acute myeloid leukaemia

Clinical tumor cell distribution pattern is a prognostically relevant parameter in patients with B-cell chronic lymphocytic leukemia

B and CTL responses to the ALK protein in patients with ALK‐positive ALCL

PARATHYROID HORMONE RELATED PROTEIN (PTHrP) IN ACUTE MYELOID LEUKAEMIA CELLS

Suchergebnisse filtern